Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2690
-0.0102 (-3.65%)
At close: Apr 1, 2025, 4:00 PM
0.2842
+0.0152 (5.66%)
After-hours: Apr 1, 2025, 4:19 PM EDT
Cyclacel Pharmaceuticals Employees
Cyclacel Pharmaceuticals had 12 employees as of December 31, 2019. The number of employees decreased by 2 or -14.29% compared to the previous year.
Employees
12
Change (1Y)
-2
Growth (1Y)
-14.29%
Revenue / Employee
$6,167
Profits / Employee
-$1,123,417
Market Cap
66.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CYCC News
- 8 days ago - Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - GlobeNewsWire
- 4 weeks ago - Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership - GlobeNewsWire
- 3 months ago - Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - GlobeNewsWire